Endoscopic Devices - Belgium | Statista Market Forecast

In Belgium, revenue in the Endoscopic Devices market market is projected to reach US$224.50m in 2024.
The revenue is anticipated to demonstrate an annual growth rate (CAGR 2024-2029) of 6.38%, which will lead to a market volume of US$305.90m by 2029.
In a global context, the majority of revenue will be generated the United States, with a figure of US$10.39bn in 2024.
Belgium's medical technology sector is increasingly integrating advanced endoscopic devices, reflecting a growing emphasis on minimally invasive surgical techniques among healthcare providers.

Definition:
The Endoscopic Devices market, a medical technology market, includes the sale of endoscopic devices. Endoscopy involves the use of an endoscope to examine the inside of a hollow organ or body cavity. The market includes various types of endoscopes, such as gastroscopes, laparoscopes, bronchoscopes, and colonoscopes.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Olympus Corporation, Boston Scientific Corporation, and Stryker Corporation. Further information on the key players can be found in the Market Shares boxes.

Endoscopic devices
Implants such as stents

pharmaceuticals for endoscopic procedure

The Endoscopic Devices Market within the Medical Devices sector in Belgium is experiencing moderate growth, influenced by factors such as technological advancements, increasing prevalence of chronic diseases, and rising demand for minimally invasive procedures among healthcare providers.

Customer preferences: Consumers in Belgium are increasingly prioritizing personalized healthcare solutions, leading to heightened interest in advanced endoscopic devices that offer tailored treatment options. This shift is partly influenced by a growing awareness of the benefits of preventive care and early diagnosis, particularly among aging demographics. Additionally, the demand for minimally invasive procedures is rising, as patients seek quicker recovery times and less postoperative pain. Cultural attitudes towards health are evolving, with a greater emphasis on convenience and efficiency in healthcare delivery, further driving market growth.

Trends in the market: In Belgium, the Endoscopic Devices Market is experiencing a surge in demand for innovative technologies that enhance diagnostic precision and treatment efficacy. This trend is driven by an increasing preference for minimally invasive surgical techniques, which promise shorter recovery times and reduced postoperative complications. Additionally, advancements in imaging technologies are facilitating more accurate and timely diagnoses, appealing to an aging population concerned with preventive care. As healthcare providers adopt these sophisticated devices, the implications for industry stakeholders include the need for continuous innovation, strategic partnerships, and investment in training to ensure optimal utilization of these advanced tools.

Local special circumstances: In Belgium, the Endoscopic Devices Market is shaped by a robust regulatory framework that emphasizes patient safety and product efficacy, influencing the pace of innovation. The country's centralized healthcare system promotes equitable access to advanced medical technologies, encouraging hospitals to invest in cutting-edge endoscopic solutions. Additionally, Belgium's multilingual population necessitates tailored educational programs for healthcare professionals, ensuring effective training on new devices. Cultural preferences for minimally invasive procedures further drive demand, positioning Belgium as a key player in the European endoscopic landscape.

Underlying macroeconomic factors: The Endoscopic Devices Market in Belgium is significantly influenced by macroeconomic factors, including national economic stability, healthcare expenditure, and investment in medical technology. A strong national economy fosters increased government and private sector funding for healthcare, enabling hospitals to acquire advanced endoscopic devices. Moreover, Belgium's commitment to research and development, supported by fiscal policies that incentivize innovation, bolsters the market's growth. Global trends, such as the rising preference for minimally invasive surgeries and an aging population, further enhance demand for endoscopic solutions, positioning Belgium as a pivotal market within Europe’s medical technology landscape.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.